Video
Sacral neuromodulation shows efficacy in OAB patients with Parkinson’s disease
Author(s):
“Of those patients that did the test phase 82% of them actually went on to full implants,” says Sarah Martin, DO.
Video Player is loading.
In this video, Sarah Martin, DO, discusses the background and key findings from the recent Neurourology & Urodynamics study, “Is sacral neuromodulation effective in patients with Parkinson's disease? A retrospective review,” for which she served as first author. Martin is an FPMRS fellow at Glickman Urological & Kidney Institute at Cleveland Clinic.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Joseph Song, MD, on the emergence of new suction-based devices for stone disease
How eating disorders affect bladder and pelvic floor health
Sarah Razavi, MD, outlines strategies for mitigate surgeon discomfort during URS
Can ctDNA detect molecular residual disease in NMIBC?
Expert discusses setting realistic expectations for Rezum for BPH
Nicolette G. Payne, MD, discusses risk factors for burnout among pediatric urologists
Sacral neuromodulation device empowers patients with greater UUI control
Howard Goldman, MD, on his experience with the Glean Urodynamics System
Study: Women with SCI are more likely to use indwelling catheters
Ziho Lee, MD, previews 2025 Northwestern GU robotic reconstruction course
Related Content
